SEC Charges Cassava Sciences, Two Former Executives for Misleading Claims About Alzheimer’s Clinical Trial

Sep 26, 2024

The Securities and Exchange Commission today announced Cassava Sciences, Inc., its founder and former CEO, Remi Barbier, and its former Senior Vice President of Neuroscience, Dr. Lindsay Burns, will pay more than $40 million to settle charges related to…

Full report at: Read More

More News

Former Connecticut-Based Energy Trader Convicted of International Bribery Scheme

FROM: Latest News

Amazon, FBI, DOJ, and a Fabricated Multi-Million Dollar Kickback Scheme: How Lies Almost Destroyed a Self-Made Man

FROM: Real Estate Law

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

SEC Charges Cassava Sciences, Two Former Executives for Misleading Claims About Alzheimer’s Clinical Trial

More News

Hernandez Sunosky, LLP Secures Major Settlement in Motorcycle Accident Case

Daily Journal names WSHB’s Constance Endelicato to Top Women Lawyers List

SEC Charges Three New Yorkers for Raising More Than $184 Million Through Pre-IPO Fraud Schemes

Pittsburgh Resident Sentenced to Two Years’ Probation and a Restitution Amount of $109,413.90 for Conviction of Theft of Government Property

Veterans and survivors have filed more than 500,000 toxic exposure-related benefits claims under the PACT Act

Top Dog Law Expands Reach with Grand Opening of New Milton, Massachusetts Office

Former Connecticut-Based Energy Trader Convicted of International Bribery Scheme

Amazon, FBI, DOJ, and a Fabricated Multi-Million Dollar Kickback Scheme: How Lies Almost Destroyed a Self-Made Man